TAAR1 and schizophrenia: We provide an overview of TAAR1′s role in regulating monoaminergic and glutamatergic circuits implicated in schizophrenia pathophysiology, and discuss the potential for TAAR1 agonists in psychosis, negative symptomatology, cognition, mood, and anxiety as they relate to schizophrenia.